Package 65862-174-60

{"route": ["ORAL"], "spl_id": "cc3c1e0b-a614-4bec-8af7-8074af598df4", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0365862171603", "0365862172600"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_set_id": ["32b48ea0-a215-43b8-83b4-a5435a686d68"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (65862-174-05)", "package_ndc": "65862-174-05", "marketing_start_date": "20220411"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (65862-174-60)", "package_ndc": "65862-174-60", "marketing_start_date": "20090327"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (65862-174-99)", "package_ndc": "65862-174-99", "marketing_start_date": "20220411"}], "brand_name": "Topiramate", "product_id": "65862-174_cc3c1e0b-a614-4bec-8af7-8074af598df4", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "65862-174", "generic_name": "Topiramate", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "200 mg/1"}], "application_number": "ANDA078462", "marketing_category": "ANDA", "marketing_start_date": "20090327", "listing_expiration_date": "20261231"}